BMN.AX - Stock quotes
Stock Quotes Home
Live Stock Quotes - Symbol Lookup
Enter Symbol


Chart for ticker : 0.220
Ticker : BMN.AX
Last Trade : 0.220
Last Trade At : 2/8/2012 12:10am
Change : -0.005
Opened At : 0.220
Day Range : 0.230 - 0.220
Volume : 583620
More Details: http://finance.yahoo.com/q?s=BMN.AX

Data delayed by 15 minutes

Detailed Chart for BMN.AX and Technical Analysis

News Headlines for BMN.AX
IMPORTANT: Bing News RSS feed has moved!
table bgColorffffbb border1pxtdGo to thenbspa hrefhttpapi.bing.comrss.aspxSourceNewsampMarketen-USampVersion2.0 ampQueryBMN.AXnew RSS pageanbspand renew your subscription.tdtable
Bannerman Discovers Near-Surface Mineralisation Beyond Planned Pit Outline
PERTH AUSTRALIA -- Marketwire -- 012412 -- Bannerman Resources Limited TSXBANASXNSX Bannerman or the Company is pleased to report significant new drilling results from the recently completed RC drilling program in the Onkelo area ...
BioMarin Seeks to Buttress Rare-Disease Push With Deals
Suitors he said would probably prefer to wait for definitive data on GALNS and the Pompe disease drug -701 before considering a bid. BioMarin has said it anticipates -701 will start the last phase of testing usually needed for U.S ...
Bannerman Resources Limited : Bannerman CEO Boardroom Radio Interview
Perth Australia - Bannerman Resources Limited ASX TSX BAN NSX Bannerman or the Company provides the opportunity for shareholders and investors to hear an interview by the Companys Chief Executive Officer Len Jubber regarding ...
Bannerman Advances Etango DFS and Discovers New Mineralisation
NOT FOR DISTRIBUTION TO UNITED STATES NEWS SERVICES OR FOR DISSEMINATION INTO THE UNITED STATES Bannerman Resources Limited TSXBANASXNSX Bannerman or the Company is pleased to announce highlights from its December 2011 Quarterly ...
BioMarin CEO Seeking Deals to Expand Push for Treatments of Rare Diseases
Suitors he said would probably prefer to wait for definitive data on GALNS and the Pompe disease drug -701 before considering a bid. BioMarin has said it anticipates -701 will start the last phase of testing usually needed for U.S ...
BioMarin perfects the popular rare disease drug model
BioMarins -111 is just entering human trials. Its designed to correct the genetic defect through daily injections. And while the treatment is intended to correct the height of children after they are initially diagnosed investigators ...
BioMarin to Present at the BIO CEO & Investor Conference
-701 a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase IGF2-GAA which is currently in Phase III clinical development for the treatment of Pompe disease and -673 a poly ADP-ribose polymerase PARP inhibitor ...
Smartphones power record Samsung profit
Seoul Jan 27 bdnews24.comReuters - Samsung Electronics Co posted a record 4.7 billion quarterly operating profit driven by booming smartphone sales and will spend 22 billion this year to boost production of chips and flat screens to pull further ...
Look back...who owns Rock and Roll in 2012?
Two tribute bands RAIN and Beatlemania NOW s home base is Delaware County Pa. continue to tour the world and play pop songs that were written 40 to 50 years ago. The Beatles first single Love Me Do became a modest hit in ...

Live Stock Quotes
Enter Symbol

Home | About |  Directory |  Contact |  News |  Newsletter | www.finance.com.au